Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-06-09
2010-11-23
Kapushoc, Stephen (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C536S024300, C536S023100, C435S091200
Reexamination Certificate
active
07838224
ABSTRACT:
The invention concerns sensitive methods to measure mRNA levels in biopsied tumor tissues, including archived paraffin-embedded biopsy material. The invention also concerns breast cancer gene sets important in the diagnosis and treatment of breast cancer, and methods for assigning the most optimal treatment options to breast cancer patient based upon knowledge derived from gene expression studies.
REFERENCES:
patent: 4699877 (1987-10-01), Cline et al.
patent: 5015568 (1991-05-01), Tsujimoto et al.
patent: 5459251 (1995-10-01), Tsujimoto et al.
patent: 5563035 (1996-10-01), Weigel
patent: RE35491 (1997-04-01), Cline et al.
patent: 5858678 (1999-01-01), Chinnadurai
patent: 5952179 (1999-09-01), Chinnadurai
patent: 5985553 (1999-11-01), King et al.
patent: 6180333 (2001-01-01), Giordano
patent: 6207452 (2001-03-01), Govindaswamy
patent: 6271002 (2001-08-01), Linsley et al.
patent: 6316208 (2001-11-01), Roberts et al.
patent: 6322986 (2001-11-01), Ross
patent: 6331396 (2001-12-01), Silverman et al.
patent: 6414134 (2002-07-01), Reed
patent: 6582919 (2003-06-01), Danenberg
patent: 6602670 (2003-08-01), Danenberg
patent: 6618679 (2003-09-01), Loehrlein et al.
patent: 7081340 (2006-07-01), Baker et al.
patent: 2002/0009736 (2002-01-01), Wang
patent: 2003/0073112 (2003-04-01), Zhang et al.
patent: 2003/0104499 (2003-06-01), Pressman et al.
patent: 2003/0165952 (2003-09-01), Linnarsson et al.
patent: 2003/0180791 (2003-09-01), Chinnadurai
patent: 2003/0198970 (2003-10-01), Roberts
patent: 2003/0225528 (2003-12-01), Baker et al.
patent: 2004/0009489 (2004-01-01), Golub et al.
patent: 2004/0133352 (2004-07-01), Bevilacqua et al.
patent: 2004/0209290 (2004-10-01), Cobleigh et al.
patent: 2006/0286565 (2006-12-01), Baker et al.
patent: 2007/0059737 (2007-03-01), Baker et al.
patent: 2007/0065845 (2007-03-01), Baker et al.
patent: 2007/0141587 (2007-06-01), Baker et al.
patent: 2007/0141588 (2007-06-01), Baker et al.
patent: 2007/0141589 (2007-06-01), Baker et al.
patent: 0 108 564 (1988-05-01), None
patent: 1 365 034 (2003-11-01), None
patent: 2003-576654 (2010-03-01), None
patent: 2006-40014 (2010-03-01), None
patent: WO 98/33450 (1998-08-01), None
patent: WO 99/02714 (1999-01-01), None
patent: WO 00/50595 (2000-08-01), None
patent: WO 00/55173 (2000-09-01), None
patent: WO 00/55629 (2000-09-01), None
patent: WO 00/60076 (2000-10-01), None
patent: WO 01/04343 (2001-01-01), None
patent: WO 01/25250 (2001-04-01), None
patent: WO 01/40466 (2001-06-01), None
patent: WO 01/40517 (2001-06-01), None
patent: WO 01/55320 (2001-08-01), None
patent: WO 01/70979 (2001-09-01), None
patent: WO 02/00677 (2002-01-01), None
patent: WO 02/06526 (2002-01-01), None
patent: WO 02/08228 (2002-01-01), None
patent: WO 02/08260 (2002-01-01), None
patent: WO 02/08261 (2002-01-01), None
patent: WO 02/08765 (2002-01-01), None
patent: WO 02/10436 (2002-02-01), None
patent: WO 02/46467 (2002-06-01), None
patent: WO 02/17852 (2002-07-01), None
patent: WO 02/055988 (2002-07-01), None
patent: WO 02/059271 (2002-08-01), None
patent: WO 02/059377 (2002-08-01), None
patent: WO 02/068579 (2002-09-01), None
patent: WO 02/103320 (2002-12-01), None
patent: WO 03/011897 (2003-02-01), None
patent: WO 03/083096 (2003-10-01), None
Lucentini, Jack. Gene Association Studies Typically Wrong. 2004. The Scientist vol. 18, pp. 1-3.
Wu, Thomas. Analyzing gene expression data from DNA microarrays to identify candidate genes. 2001. Journal of Pathology. vol. 195 pp. 53-65.
Unger, Meredith et al. Characterization of adjacent breast tumors using oliognucleotide microarrays. 2001 Breast Cancer Research vol. 3 pp. 336-341.
Specht, Katja et al. Quantitative gene expression analysis in microdissected archival fomalin fixed and paraffin embedded tumor tissue. 2001 American Journal of Pathology. vol. 158 pp. 419-429.
Sorlie, Therese. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. 2001 PNAS vol. 98 pp. 10869-10874.
The array finder at www.affymetrix.com accessed Jul. 23, 2008 demonstrates that probes of the ESR1 gene are one the HU95A array.
The array finder at www.affymetrix.com accessed Jul. 23, 2008 demonstrates that probes of the BIRC5 gene are one the HU95A array.
Nasu, Shunichi et al. Survivin mRNA expression in patients with breast cancer. 2002. Anticancer Research vol. 22 pp. 1839-1843.
Chan, Eric. Integrating Transcriptomics and Proteomics. 2006. Genomics and Proteomics, avaliable online from www.genpromag.com, pp. 1-6.
Schmittgen, Thomas, et al. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients. 2003 International Jouranl of Cancer. vol. 107 pp. 323-329.
The Gene Card for ESR1 found online at http://www.genecards.org/cgi-bin/carddisp.pl?gene=ESR1&search=esr1 accessed Mar. 5, 2009.
The Gene Card for BIRC5 found online at http://www.genecards.org/cgi-bin/carddisp.pl?gene=BIRC5&search=birc5 accessed Mar. 5, 2009.
Affymetrix Inc.: “Affymetrix GeneChip Human Genome U95 Version 2 Set HG-U95A,” GEO, XX, XX, 1-243 (2002).
Bhattacharjee et al., “Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses”, Proceedings of the National Academy of Sciences of USA, vol. 98, No. 24, pp. 13790-13795 (2001).
Chang, J. et al, “Biologic Markers as Predictors of Clinical Outcome from Systemic Therapy for Primary Operable Breast Cancer,”Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol. 17:(10) 3058-3063 (1999).
Chen-Hsiang Yeang et al., “Molecular Classification of Multiple Tumor Types”, Bioinformatics, vol. 37, Suppl. 1, pp. S316-S322 (2001).
Cox, G. et al., “Bcl-2 is an Independent Prognostic Factor and Adds to a Biological Model for Predicting Outcome in Operable Non-Small Cell Lung Cancer,”Lung Cancer, vol. 34:(3) 417-426 (2001).
Dijkema, I.M. et al., “Influence of p53 and bcl-2 on Proliferative Activity and Treatment Outcome in head and Neck Cancer Patients,”Oral Oncology, Elsevier Science, vol. 36:(1) 54-60 (2000).
Golub et al., “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring”, Science, vol. 286, pp. 531-537 (1999).
Guerin, M. et al., “Structure and Expression of C-ERBB-2 and EGF Receptor Genes in Inflammatory and Non-Inflammatory Breast Cancer: Prognostic Significance,”International Journal of Cancer, vol. 43 201-208 (1989).
Joensuu, H. et al., “Bcl-2 Protein Expression and Long-Term Survival in Breast Cancer,”American Journal of Pathology, vol. 145:(5) 1191-1198 (1994).
Kymionis, G.D., et al., “Can Expression of Apoptosis Genes, bcl-2 and Bax, Predict Survival and Responsiveness to Chemotherapy in Node-Negative Breast Cancer Patients?”The Journal of Surgical Research, vol. 99:(2) 161-168 (2001).
Locker, A.P. et al., “Ki67 immunoreactivity in Breast Carcinoma: Relationships to prognostic Variable and Short time Survival,”European Journal of Surgical Oncology, vol. 18:(3) 224-229 (1992).
Martin et al., “Linking Gene Expression Patterns to Therapeutic Groups in Breast Cancer”, Cancer Research, vol. 60. pp. 2232-2238 (2000).
Murray, P.A. et al., “The Prognostic Significance of Transforming Growth Factors in Human Breast Cancer,”British Journal of Cancer, vol. 67:(6) 1408-1412 (1993).
Perou et al., “Molecular portraits of human breast tumors”, Nature, vol. 406, pp. 747-752 (2000).
Ramaswamy et al., “Multiclass cancer diagnosis using tumor gene expression signatures”, Proceedings of the National Academy of Sciences of USA, vol. 98, No. 26, pp. 15149-15154 (2001).
Sens, Mary Ann et al.,“Metallothionein Isoform 3 Overexpression is Associated with Breast Cancers Having a Poor Prognosis,”American Journal of Pathology, vol. 159:(1) 21-26 (2001).
Sorlie et al., “Gene Expression patterns of breast carcinomas distinguish tumor subclass with clin
Baker Joffre B.
Cronin Maureen T.
Kiefer Michael C.
Shak Steve
Walker Michael Graham
Bozicevic Field & Francis LLP
Francis Carol L.
Genomic Health, Inc.
Kapushoc Stephen
Keddie James S.
LandOfFree
Gene expression profiling in biopsied tumor tissues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene expression profiling in biopsied tumor tissues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene expression profiling in biopsied tumor tissues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4248754